This is a preview of subscription content, log in via an institution to check access.
Notes
2016 US dollars
Reference
Ford DC, et al. Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients. American Journal of Health-System Pharmacy : 14 Jun 2018. Available from: URL: http://doi.org/10.2146/ajhp170554
Rights and permissions
About this article
Cite this article
Vancomycin cost effective for C. difficile infection. PharmacoEcon Outcomes News 806, 33 (2018). https://doi.org/10.1007/s40274-018-5076-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5076-y